Eastern Cooperative Oncology GroupAmerican Joint Committee on Cancer stage IVipilimumabnivolumabinfliximabmycophenolate mofetilirHepatitis
…n).Results All patients received ipilimumab plus nivolumab. The Eastern Cooperative Oncology Group performance status was 0 in 75.0% of patients, and nearly all (…